B&K CORP-B (02396) recommends the Caina Technology Incentive Plan.

date
21:17 14/08/2026
avatar
GMT Eight
Qingcheng New Medicine-B (02396) announced that on August 14, 2026, the board of directors approved the proposal for a share incentive plan, which is subject to shareholder approval. The share incentive plan constitutes a share scheme under Chapter 17 of the Listing Rules and will therefore comply with the provisions of Chapter 17 of the Listing Rules. On August 14, 2026, the board of directors decided to make the first conditional grant of awards to one employee and one consultant under the share incentive plan.
B&K CORP-B (02396) announced that on August 14, 2026, the board of directors approved the proposed Caina Technology incentive plan, which is subject to shareholder approval. The share incentive plan constitutes a share scheme under Chapter 17 of the Listing Rules, and therefore will comply with the provisions of Chapter 17 of the Listing Rules. On August 14, 2026, the board of directors decided to grant the first conditional awards under the share incentive plan to one employee and one consultant.